Printer Friendly
The Free Library
14,530,717 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Henry Schein Reports Record Quarterly Results; Diluted EPS of $0.87 includes $0.11 related to earlier shipments of influenza vaccine.


Business Editors

MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 5, 2002

Henry Schein Henry Schein Inc. is a Fortune 500 company based in Melville, New York. It is a distributor of healthcare products and services primarily to office-based healthcare practitioners in the North American and European markets. The Company operates in two business segments. , Inc. (Nasdaq NM: HSIC HSIC High Speed Inter-Chip (USB)
HSIC High Speed Integrated Circuit
), the largest provider of healthcare products and services to office-based practitioners in the combined North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 and European European

emanating from or pertaining to Europe.


European bat lyssavirus
see lyssavirus.

European beech tree
fagussylvaticus.

European blastomycosis
see cryptococcosis.
 markets, today reported financial results for the three months ended September September: see month.  28, 2002.

Net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 for the third quarter of 2002 were $759.1 million, an increase of 15.1% from the third quarter of 2001 (13.8% in local currencies). Net income for the third quarter of 2002 was $39.2 million, a 55.7% increase over the prior-year quarter. Earnings per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share were $0.87 in the third quarter of 2002, up 50%. Compared to the prior year third quarter, Dental dental /den·tal/ (den´t'l) pertaining to a tooth or teeth.

den·tal
adj.
1. Of, relating to, or for the teeth.

2. Of, relating to, or intended for dentistry.
 sales grew by 7.6% (5.5% merchandise MERCHANDISE. By this term is understood all those things which merchants sell either wholesale or retail, as dry goods, hardware, groceries, drugs, &c. It is usually applied to personal chattels only, and to those which are not required for food or immediate support, but such as remain , 16.9% equipment), Medical sales improved by 23.4%, Technology and Value-Added Services A value-added service (VAS) is a telecommunications industry term for non-core services or, in short, all services beyond standard voice calls and fax transmissions.  sales grew by 25.0%, and International sales improved by 11.4% (2.1% in local currencies).

In order to effectively analyze an·a·lyze
v.
1. To examine methodically by separating into parts and studying their interrelations.

2. To separate a chemical substance into its constituent elements to determine their nature or proportions.

3.
 third quarter 2002 results, the Company indicated that several factors should be taken into consideration;
-- Influenza vaccine sales occurred earlier this year than last year. This timing shift, between the third and fourth quarters of 2002, equated to approximately $44 million of sales which, net of related costs and expenses, accounted for approximately $0.11 of the third quarter earnings per diluted share.

-- As part of our new Dental marketing initiative, MarketOne, certain technology and equipment products are now being sold directly to end-user customers rather than through resellers resulting in a higher growth rate for the Technology and Value-Added Service category. Without this change that category grew by 19.6%. Worldwide and Dental sales were immaterially affected, and the other categories were not affected.

-- Third quarter Other Income included a net $1.4 million pre-tax ($890,000 after-tax) gain, or approximately $0.02 per diluted share, primarily related to settlement of a real estate transaction.

-- 2002 results are reported in compliance with SFAS 142, which eliminated amortization of goodwill. Growth in net income and earnings per diluted share are 45.2% and 40.3%, respectively, if goodwill amortization were removed from 2001 results.


"Our overall third quarter financial performance was excellent by any measure, and we are proud to report another quarter of strong growth in net sales, operating income Operating Income

The profit realized from a business' own operations.

Notes:
This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit.
, net income and EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. ," said Stanley Stanley, town (1991 pop. 1,557), capital of the Falkland Islands, S Atlantic Ocean, on East Falkland island. It is the main port and trading center of the islands. The name is sometimes written as Port Stanley.  M. Bergman, Chairman, Chief Executive Officer and President of Henry Schein. "Our Dental, Medical, and Technology and Value-Added Services business Groups reported market share gains during the third quarter. Dental sales were up nearly 8% including equipment up nearly 17%, Medical sales to our core physician and alternate-care customers without the positive timing impact of influenza vaccine influenza vaccine Flu vaccine A vaccine recommended for those at high risk for serious complications from influenza: > age 65; Pts with chronic diseases of heart, lung or kidneys, DM, immunosuppression, severe anemia, nursing home and other chronic-care  sales were up 9%, and Technology and Value-Added Services sales were up about 20%."

"We are particularly happy with continued gains in our Dental equipment sales and service revenues, which is a direct result of investments made in this segment of our business, and is a positive indicator Indicator

Anything used to predict future financial or economic trends.

Notes:
In the context of technical analysis, an indicator is a mathematical calculation based on a securities price and/or volume. The result is used to predict future prices.
 for future Dental sales growth," stated Mr. Bergman. "At the end of the third quarter, approximately ap·prox·i·mate  
adj.
1. Almost exact or correct: the approximate time of the accident.

2.
 8,000 dental customers were enrolled in our Privileges privileges,
n the authority granted to a physician or dental professional by a hospital governing board to provide patient care in the hospital. Clinical privileges are limited to the individual's license, experience, and competence.
 customer-loyalty program, and results indicate that these customers are purchasing at a rate significantly above our average customer."

Commenting on the Company's Medical Group, Mr. Bergman said, "We are pleased to report that our Medical Group's sales growth of approximately 9% to physician and alternate alternate /al·ter·nate/ (awl´ter-nit)
1. following in turns.

2. pertaining to every other one in a series.

3. occurring in place of another; acting as a substitute.
 care customers, without the positive timing impact of influenza vaccine sales, is three to four percentage points above estimated market growth rates Growth Rates

The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures.

Notes:
Remember, historically high growth rates don't always mean a high rate of growth looking into the future.
."

For the first nine months of 2002, net sales were $2.08 billion, an increase of 11.7% compared with the first nine months of 2001 (11.3% in local currencies). Net income for the first nine months of 2002 was $87.0 million, a 44.5% increase over the prior year. Earnings per diluted share for the first nine months of 2002 were $1.94, up 39.6% compared with the prior-year period. The Company noted that for analysis purposes, the third quarter factors listed above should also be taken into consideration when viewing year-to-date Year-to-date (YTD)

The period beginning at the start of the calendar year up to the current date.
 results.

Regarding the outlook for the remainder of 2002, based on the strength of year-to-date financial results the Company now expects full-year 2002 earnings per diluted share to increase to $2.58-$2.60.

Mr. Bergman noted that the Company looks forward to an Analyst/Investor Day on November November: see month.  21, 2002, starting at 8 a.m. Eastern Time. "We will introduce 2003 financial guidance at this event, as well as provide an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 look at our Company and our plans," he added.

The Company welcomes professional money managers and securities analysts to attend its Analyst/Investor Day in person, and registration can be completed at www.henryschein.com. For those not attending in person, a live and 30-day archived Webcast of the entire event will be available on the Company's Website.

Third Quarter Conference Call Webcast

The Company will hold a conference call to discuss third quarter financial results today, beginning at 10 a.m. Eastern Time. Individual investors are invited to listen to the conference call over the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 through Henry Schein's Website at www.henryschein.com. In addition, a replay will be available for 30 days beginning shortly after the call has ended.

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. Recognized for its excellent customer service and low prices, the Company serves more than 400,000 customers worldwide, including dental practices Noun 1. dental practice - the practice of dentistry
practice - the exercise of a profession; "the practice of the law"; "I took over his practice when he retired"
 and laboratories, physician practices and veterinary veterinary /vet·er·i·nary/ (vet´er-i-nar?e)
1. pertaining to domestic animals and their diseases.

2. veterinarian.


vet·er·i·nar·y
adj.
 clinics, as well as government and other institutions.

The Company operates its four business groups - Dental, Medical, International and Technology - through a centralized cen·tral·ize  
v. cen·tral·ized, cen·tral·iz·ing, cen·tral·iz·es

v.tr.
1. To draw into or toward a center; consolidate.

2.
 and automated au·to·mate  
v. au·to·mat·ed, au·to·mat·ing, au·to·mates

v.tr.
1. To convert to automatic operation: automate a factory.

2.
 distribution network, which provides customers in more than 125 countries with a comprehensive selection of over 80,000 national and Henry Schein private-brand products. Henry Schein also offers a wide range of innovative value-added val·ue-add·ed
adj.
Of or relating to the estimated value that is added to a product or material at each stage of its manufacture or distribution:
 practice solutions, including such leading practice management software systems as DENTRIX Dentrix Dental Systems, a division of Sullivan-Schein Dental, sells and supports DENTRIX and Easy Dental (dental practice management software). Dentrix was the first practice management software for Windows in 1989. (R) and Easy Dental(R) for dental practices, and AVImark(R) for veterinary clinics, which are installed in over 44,000 practices; and ArubA Aruba (ər`bə), island, autonomous part of the Netherlands (2005 est. pop. 71,600), 69 sq mi (179 sq km), in the Lesser Antilles off the coast of Venezuela. (R), Henry Schein's electronic catalog catalog, descriptive list, on cards or in a book, of the contents of a library. Assurbanipal's library at Nineveh was cataloged on shelves of slate. The first known subject catalog was compiled by Callimachus at the Alexandrian Library in the 3d cent. B.C.  and ordering system. Headquartered in Melville, New York Melville is a hamlet and census-designated place in the town of Huntington in Suffolk County on Long Island, New York, in the United States. As of the 2000 census, 14,533 people resided there. , Henry Schein employs over 6,700 people in 16 countries. The Company's 2001 sales reached a record $2.6 billion. For more information, visit the Henry Schein Website at www.henryschein.com.

Certain information contained herein includes information that is forward-looking for·ward-look·ing
adj.
Concerned with or making provision for the future: forward-looking educators; a forward-looking corporate plan.

Adj. 1.
. The matters referred to in forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 may be affected by the risks and uncertainties involved in the Company's business. These forward-looking statements are qualified in their entirety The whole, in contradistinction to a moiety or part only. When land is conveyed to Husband and Wife, they do not take by moieties, but both are seised of the entirety.  by the cautionary statements contained in the Company's Securities and Exchange Commission filings.

                  HENRY SCHEIN, INC. AND SUBSIDIARIES
                   CONSOLIDATED STATEMENTS OF INCOME
                 (in thousands, except per share data)
                              (unaudited)

                        Three Months Ended       Nine Months Ended
                     ----------------------    ----------------------
                      Sept. 28,   Sept. 29,     Sept. 28,   Sept. 29,
                        2002        2001          2002         2001
                     ----------  ----------    ----------  ----------

Net sales            $  759,073  $  659,774    $2,077,598  $1,859,954
Cost of sales           542,601     480,918     1,490,340   1,354,849
                     ----------  ----------    ----------  ----------
    Gross profit        216,472     178,856       587,258     505,105
Operating expenses:
  Selling, general
   and administrative   152,187     136,981       440,786     400,375
                     ----------  ----------    ----------  ----------
    Operating income     64,285      41,875       146,472     104,730
Other income
 (expense):
  Interest income         2,536       2,266         7,456       6,684
  Interest expense       (4,787)     (3,843)      (13,982)    (14,107)
  Other - net               877          87         1,017         384
                     ----------  ----------    ----------  ----------
    Income before
     taxes on income,
     minority
     interest and
     equity in
     earnings of
     affiliates          62,911      40,385       140,963      97,691
Taxes on income          23,468      14,942        52,528      36,146
Minority interest in
 net income of
 subsidiaries               337         322         1,838       1,647
Equity in earnings of
 affiliates                 122          74           427         339
                     ----------  ----------    ----------  ----------
Net income           $   39,228  $   25,195    $   87,024  $   60,237
                     ==========  ==========    ==========  ==========
Net income per
 common share:
  Basic              $     0.90  $     0.59    $     2.01  $     1.42
                     ==========  ==========    ==========  ==========
  Diluted            $     0.87  $     0.58    $     1.94  $     1.39
                     ==========  ==========    ==========  ==========
Weighted average
 common shares
 outstanding:
  Basic                  43,808      42,488        43,329      42,276
                     ==========  ==========    ==========  ==========
  Diluted                45,000      43,517        44,779      43,188
                     ==========  ==========    ==========  ==========


               HENRY SCHEIN, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS
               (in thousands, except share data)

                                                Sept. 28,   Dec. 29,
                                                  2002        2001
                                               ----------  ----------
                                              (unaudited)  (audited)
  ASSETS
Current assets:
  Cash and cash equivalents                    $  149,299  $  193,367
  Marketable securities                            35,285           0
  Accounts receivable, less reserves of $33,088
   and $31,929, respectively                      415,585     363,700
  Inventories                                     314,499     291,231
  Deferred income taxes                            29,168      25,751
  Prepaid expenses and other                       63,123      52,922
                                               ----------  ----------
      Total current assets                      1,006,959     926,971
Property and equipment, net of accumulated
 depreciation and amortization of $101,060
 and $90,823, respectively                        137,163     117,980
Goodwill, net                                     294,439     279,981
Other intangibles, net of accumulated
 amortization of $4,160 and $3,348,
 respectively                                       8,919       8,023
Investments and other                              69,652      52,473
                                               ----------  ----------
                                               $1,517,132  $1,385,428
                                               ==========  ==========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Accounts payable                             $  260,197  $  263,190
  Bank credit lines                                 6,081       4,025
  Accruals:
    Salaries and related expenses                  42,920      41,602
    Merger and integration, and restructuring
     costs                                          4,308       5,867
    Acquisition earnout payments                        0      26,800
    Taxes and other expenses                      110,470      80,355
  Current maturities of long-term debt              2,665      15,223
                                               ----------  ----------
      Total current liabilities                   426,641     437,062
Long-term debt                                    242,140     242,169
Other liabilities                                  21,077      18,954
                                               ----------  ----------
      Total liabilities                           689,858     698,185
                                               ----------  ----------
Minority interest                                   7,067       6,786
                                               ----------  ----------
Stockholders' equity:
  Preferred stock, $.01 par value, authorized
   1,000,000, issued and outstanding: 0 and 0,
   respectively                                         0           0
  Common stock, $.01 par value, authorized
   120,000,000, issued: 43,999,524 and
   42,745,204, respectively                           440         427
  Additional paid-in capital                      435,021     393,047
  Retained earnings                               399,426     312,402
  Treasury stock, at cost, 62,479 shares           (1,156)     (1,156)
  Accumulated comprehensive loss                  (13,277)    (23,922)
  Deferred compensation                              (247)       (341)
                                               ----------  ----------
      Total stockholders' equity                  820,207     680,457
                                               ----------  ----------
                                               $1,517,132  $1,385,428
                                               ==========  ==========


                  HENRY SCHEIN, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (in thousands)
                              (unaudited)

                       Three Months Ended         Nine Months Ended
                     ----------------------    ----------------------
                      Sept. 28,   Sept. 29,     Sept. 28,   Sept. 29,
                         2002        2001          2002        2001
                     ----------  ----------    ----------  ----------
Cash flows from
 operating activities:
  Net income         $   39,228  $   25,195    $   87,024  $   60,237
  Adjustments to
   reconcile net
   income to net cash
   provided by
   operating
   activities:
    Depreciation and
     amortization         7,077       9,193        20,086      26,249
    Other                  (267)      9,463         1,732       9,975
    Changes in assets
     and liabilities
     (net of purchase
     acquisitions):
      Increase in
       accounts
       receivable       (53,074)    (47,067)      (49,003)    (47,442)
      (Increase)
       decrease in
       inventories         (376)     11,691       (18,136)     24,723
      (Increase)
       decrease in
       other current
       assets            (3,955)        927        (8,662)     14,701
      Increase
       (decrease) in
       accounts payable
       and accruals      63,636      40,442        32,609      (9,320)
                     ----------  ----------    ----------  ----------
Net cash provided by
 operating activities    52,269      49,844        65,650      79,123
                     ----------  ----------    ----------  ----------
Cash flows from
 investing activities:
  Capital expenditures   (8,140)    (17,024)      (36,260)    (30,010)
  Business acquisitions,
   net of cash
   acquired                   0        (336)      (34,887)       (336)
  Purchase of
   marketable
   securities with
   maturities of more
   than three months    (29,654)          0       (50,293)          0
  Other                  (2,473)     (1,556)       (3,047)     (2,587)
                     ----------  ----------    ----------  ----------
Net cash used in
 investing activities   (40,267)    (18,916)     (124,487)    (32,933)
                     ----------  ----------    ----------  ----------
Cash flows from
 financing activities:
  Proceeds from
   issuance of
   long-term debt             0      10,166             0      10,166
  Principal payments
   on long-term debt       (784)     (8,083)      (14,388)    (11,972)
  Proceeds from
   issuance of stock
   upon exercise of
   stock options by
   employees              6,263       1,993        32,753      12,374
  Proceeds from
   borrowings from
   banks                  2,178         853         2,659       6,193
  Payments on
   borrowings from
   banks                      0      (1,149)         (916)    (12,017)
  Other                  (2,331)       (221)       (2,757)       (396)
                     ----------  ----------    ----------  ----------
Net cash provided by
 financing activities     5,326       3,559        17,351       4,348
                     ----------  ----------    ----------  ----------
Net increase
 (decrease) in cash
 and cash equivalents    17,328      34,487       (41,486)     50,538
Effect of exchange
 rate changes on cash      (537)     (2,480)       (2,582)     (1,046)
Cash and cash
 equivalents,
 beginning of period    132,508      75,847       193,367      58,362
                     ----------  ----------    ----------  ----------
Cash and cash
 equivalents, end of
 period              $  149,299  $  107,854    $  149,299  $  107,854
                     ==========  ==========    ==========  ==========
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 5, 2002
Words:2035
Previous Article:Royal Group Announces Date For Fourth Quarter Earnings Release And Conference Call.
Next Article:AmerisourceBergen Reports Record Earnings Per Share Before Special Charges of $.88 for the September Quarter and $3.29, a 42 Percent Increase, for...



Related Articles
Henry Schein Benefits From Counsel of Influenza Vaccine Expert; Noted Geriatrician, Janet McElhaney, M.D., to Focus On Influenza Vaccination...
Earnings per share up 25% for W.P. Carey & Co.(W.P. Carey adn Company L.L.C. )
REGION PREPARES FOR EXPECTED INFLUENZA OUTBREAK.(News)
Henry Schein Revises 2004 Financial Guidance Based on Chiron's Fluvirin Announcement.
Flu vaccine redirected to targeted providers.(Health)(Locally, even if rationing is successful, some high-risk patients may not get the shots,...
Henry Schein Fourth Quarter Net Sales up 26% to $1.2 Billion; Diluted EPS of $0.33 After $0.10 Charge Related to Influenza Vaccine Contract.
Henry Schein Provides 2006 Financial Guidance; Affirms 2005 Annual Guidance.
Henry Schein Reports Fourth Quarter Diluted EPS from Continuing Operations of $0.59.
Influenza vaccination during pregnancy: opinions and practices of obstetricians in an urban community.
Influenza vaccine effectiveness among US Military basic trainees, 2005-06 season.(DISPATCHES)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles